Merck News - MRK

Best deals to access real time data!
Real-time Level 1 for Canada + USA
Monthly Subscription
for only
32,99 €
Trade Alert US
Monthly Subscription
for only
52,79 €
US Markets and Indices (NYSE/NASDAQ/AMEX/DowJones/S&P)
Monthly Subscription
for only
15,62 €
VAT not included
Name Symbol Markt Aktientyp
Merck and Co Inc MRK NYSE Common Stock
  Änderung Änderung % Aktuell Hoch Niedrig Handelsbeginn Handelsende Zeit
  -0,65 -0,77% 83,80 84,65 83,7364 84,61 84,45 01:35:35
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
15.10.201923:33GLOBEBriaCell Announces Closing of Non-Brokered Private Placement..
09.10.201901:00GLOBEBriaCell Therapeutics Corp. to File Amendment to Management..
08.10.201915:55DJNMerck Cuts Emissions by 7%
08.10.201914:00BWMerck Issues 2018/2019 Corporate Responsibility Report
08.10.201910:55DJN4D Pharma Enters Vaccine Collaboration With Merck & Co.
07.10.201912:30GLOBEBriaCell Doses First Patient in Phase I/IIa Study Evaluating..
03.10.201916:39DJNPDS Biotechnology Shares Up 38% on Merck Collaboration
03.10.201915:28DJNNetScientific Shares Jump as Portfolio Company PDS..
02.10.201923:24EDGARStatement of Changes in Beneficial Ownership (4)
02.10.201923:21EDGARStatement of Changes in Beneficial Ownership (4)
02.10.201923:19EDGARStatement of Changes in Beneficial Ownership (4)
02.10.201923:13EDGARStatement of Changes in Beneficial Ownership (4)
02.10.201923:10EDGARStatement of Changes in Beneficial Ownership (4)
02.10.201914:39DJNMerck Gets China OK for Keytruda as Monotherapy for..
02.10.201913:32DJNMerck Gets FDA Priority Review of Dificid in Children
02.10.201912:45BWMerck’s KEYTRUDA® (pembrolizumab) Now Approved as..
02.10.201912:30BWFDA Accepts Two Applications for Merck’s DIFICID®..
01.10.201912:55BWMerck to Hold Third-Quarter 2019 Sales and Earnings..
01.10.201912:30GLOBENote from Chairman of BriaCell Therapeutics – October is..
30.9.201918:19DJNAstraZeneca, Merck Say Lynparza Trial Achieves Primary,..
30.9.201916:30BWLYNPARZA® (olaparib) More Than Doubled Median Radiographic..
30.9.201913:39DJNMerck: Phase 3 Study of Antibacterial Recarbrio Meets Key..
30.9.201913:06DJNWebMD Health to Buy Aptus Health From Merck
30.9.201912:55BWMerck to Present at the 2019 Cantor Fitzgerald Global..
30.9.201912:45BWPivotal RESTORE-IMI 2 Phase 3 Study of Merck’s RECARBRIO™..
29.9.201916:30BWMerck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Showed..
29.9.201908:30BWFinal Study Results Evaluating KEYTRUDA® (pembrolizumab)..
28.9.201916:30BWLYNPARZA® (olaparib) Phase 3 PAOLA-1 Trial Significantly..
25.9.201912:30GLOBEBriaCell Appoints Immunology Expert, Dr. Cara L. Haymaker,..
20.9.201917:03GLOBEBriaCell Announces Private Placement of up to $600,000
20.9.201913:52DJNMerck Gets FDA OK For Expanded Pifeltro, Delstrigo..
20.9.201912:45BWMerck’s PIFELTRO™ (doravirine) & DELSTRIGO™..
19.9.201916:00GLOBEBriaCell Announces Public Disclosure: Remarkable Responder..
19.9.201914:52DJNPDS Biotechnology Reviews Data from PDS0101 Study
17.9.201923:56BWFDA Approves KEYTRUDA® (pembrolizumab) plus LENVIMA®..
17.9.201913:29DJNMerck Gets FDA Priority Review for Investigational Ebola..
17.9.201912:45BWFDA Accepts Merck’s Biologics License Application (BLA) &..
16.9.201912:30GLOBEBriaCell to Present September 19th at 2nd Annual Next Gen..
10.9.201916:46DJNMerck Down Nearly 5%, on Pace for Largest Percent Decrease..
10.9.201914:00BWMerck Announces First Nine “Safer Childbirth Cities”..
10.9.201912:45BWPooled Analysis Continues to Show Merck’s KEYTRUDA®..
09.9.201923:33GLOBEBriaCell Announces Closing of Upsized Non-Brokered Private..
09.9.201912:45BWPivotal New Data from Merck’s Broad Oncology Portfolio at..
05.9.201912:45BWMerck to Present at the Morgan Stanley 17th Annual Global..
04.9.201914:45NNWGene Therapy Treatments Offer Hope for Cancer Patients
04.9.201914:00BWMerck Foundation Launches Five-Year Initiative to Reduce..
04.9.201913:28DJNMerck Gets Europe OK for Keytruda/Inlyta Combo in Renal Cell..
04.9.201912:45BWEuropean Commission Approves Merck’s KEYTRUDA®..
27.8.201912:30GLOBEBriaCell Announces Participation at the 21st Annual Global..
22.8.201912:45BWMerck Highlights New Data from Leading Lung Cancer Clinical..
Mehr News über diese Aktie »
Kürzlich von Ihnen besucht
NYSE
MRK
Merck
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V: D:20191018 01:13:11